New cancer clinical trial: The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors

Published on: April 25, 2018 at 12:00PM
Conditions:   Advanced Solid Tumours;   Breast Cancer;   Ovarian Cancer;   Prostate Cancer;   Primary Peritoneal Cancer
Intervention:   Drug: IMP4297
Sponsor:   Impact Therapeutics, Inc.
Recruiting
https://ift.tt/2HOt2Az